JPS6018644B2 - 膣坐薬の製造方法 - Google Patents
膣坐薬の製造方法Info
- Publication number
- JPS6018644B2 JPS6018644B2 JP49128635A JP12863574A JPS6018644B2 JP S6018644 B2 JPS6018644 B2 JP S6018644B2 JP 49128635 A JP49128635 A JP 49128635A JP 12863574 A JP12863574 A JP 12863574A JP S6018644 B2 JPS6018644 B2 JP S6018644B2
- Authority
- JP
- Japan
- Prior art keywords
- bacteria
- lactic acid
- lactobacillus
- present
- vaginal suppositories
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 239000006216 vaginal suppository Substances 0.000 title claims 3
- 238000000034 method Methods 0.000 title description 6
- 239000003242 anti bacterial agent Substances 0.000 claims description 11
- 241000186660 Lactobacillus Species 0.000 claims description 5
- 229940039696 lactobacillus Drugs 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 3
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 229940120293 vaginal suppository Drugs 0.000 claims 2
- 235000015097 nutrients Nutrition 0.000 claims 1
- 241000894006 Bacteria Species 0.000 description 40
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 35
- 235000014655 lactic acid Nutrition 0.000 description 17
- 239000004310 lactic acid Substances 0.000 description 17
- 235000019645 odor Nutrition 0.000 description 9
- 235000018185 Betula X alpestris Nutrition 0.000 description 7
- 235000018212 Betula X uliginosa Nutrition 0.000 description 7
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 210000003127 knee Anatomy 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 239000000829 suppository Substances 0.000 description 5
- 241000607598 Vibrio Species 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 206010059866 Drug resistance Diseases 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- PEJLNXHANOHNSU-UHFFFAOYSA-N acridine-3,6-diamine;10-methylacridin-10-ium-3,6-diamine;chloride Chemical compound [Cl-].C1=CC(N)=CC2=NC3=CC(N)=CC=C3C=C21.C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 PEJLNXHANOHNSU-UHFFFAOYSA-N 0.000 description 2
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- -1 Pyotin Natural products 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 241001453172 Fusobacteria Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000021048 nutrient requirements Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 208000026775 severe diarrhea Diseases 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP49128635A JPS6018644B2 (ja) | 1974-11-07 | 1974-11-07 | 膣坐薬の製造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP49128635A JPS6018644B2 (ja) | 1974-11-07 | 1974-11-07 | 膣坐薬の製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5154920A JPS5154920A (enExample) | 1976-05-14 |
| JPS6018644B2 true JPS6018644B2 (ja) | 1985-05-11 |
Family
ID=14989679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP49128635A Expired JPS6018644B2 (ja) | 1974-11-07 | 1974-11-07 | 膣坐薬の製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6018644B2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS52154590A (en) * | 1976-05-21 | 1977-12-22 | Seikenkai | Cultivating and preserving method of deodorising lactobucillus and liling cell preparation |
| ATE207755T1 (de) * | 1998-04-30 | 2001-11-15 | Vesely Renata Maria Cavaliere | Pharmazeutische zusammensetzungen enthaltend lactobacillus brevis und lactobacillus salivarius zur behandlung von vaginainfektionen |
| WO2020016461A1 (en) | 2018-09-03 | 2020-01-23 | Dsm Ip Assets B.V. | Roundsling |
-
1974
- 1974-11-07 JP JP49128635A patent/JPS6018644B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5154920A (enExample) | 1976-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4314995A (en) | Pharmaceutical lactobacillus preparations | |
| EP0208818B1 (en) | Biodeodorizer and the process for the preparation thereof | |
| US4345032A (en) | Cultivation of a deodorizing lactobacillus strain, storage thereof, and composition containing living cells thereof | |
| Dubos et al. | Indigenous, normal, and autochthonous flora of the gastrointestinal tract | |
| TWI574633B (zh) | 包含益生菌及益生質成分及礦物鹽及乳鐵蛋白之組合物 | |
| JP3186202B2 (ja) | 親生物 | |
| US4767623A (en) | Method of binding microflora and preparations therefor | |
| EP1162987B1 (en) | Pharmaceutical composition for medical and veterinary use for regenerating intestinal flora in diarrhoea or dyspeptic syndrome | |
| De Cupere et al. | Evaluation of the effect of 3 probiotics on experimental Escherichia coli enterotoxaemia in weaned piglets | |
| CA3065314A1 (en) | Compositions and methods for reducing flatulence | |
| Dudgeon | A study of the intestinal flora under normal and abnormal conditions | |
| JP4193269B2 (ja) | 新規な生体浄化活性型乳酸菌製剤 | |
| WO2025118641A1 (zh) | 一种嗜黏蛋白阿克曼氏菌vb202及其应用 | |
| US8246946B2 (en) | Treatment of bipolar disorder utilizing anti-fungal compositions | |
| EP0381700A4 (en) | Method for inhibiting the growth of _i(salmonella) | |
| CN115820499B (zh) | 一株猪源丁酸梭菌及其在调控肠道健康中的应用 | |
| JPS6018644B2 (ja) | 膣坐薬の製造方法 | |
| JP2007186529A (ja) | 悪臭ガス放出減少方法 | |
| Raja et al. | Lactobacillus as a probiotic feed for chickens | |
| RABIN et al. | Kingella kingae endocarditis in a child with a prosthetic aortic valve and bifurcation graft | |
| GB1585863A (en) | Pharmaceutical lactobacillus preparations | |
| JP2024536636A (ja) | プロテウス・ミラビリスに拮抗作用を有し、神経変性疾患に優れた効果を有する新規な菌株及びその用途 | |
| Farrell et al. | Haverhill fever: Report of a case with review of the literature | |
| JP2024131845A (ja) | Ｓｃｆａまたは乳酸の産生方法 | |
| CN112889925A (zh) | 灭活益生菌奶片及其制备方法 |